Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report

doi:10.12998/wjcc.v10.i23.8284

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 23

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3554)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

228

WORD

HTML

1892

Figures (1-3)

369

Sum=2550

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

271

Download

733

Sum=1004

Aug 16, 2022 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Aug 16, 2022; 10(23): 8284-8290
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8284

Full Size Figure Download Figure

Figure 1 Timeline of treatment course of patient with malignant pleural mesothelioma. PFS: Progression-free survival; SRS: Stereotactic radiosurgery.

Citation: Xuan TT, Li GY, Meng SB, Wang ZM, Qu LL. Immunotherapy combined with antiangiogenic agents in patients with advanced malignant pleural mesothelioma: A case report. World J Clin Cases 2022; 10(23): 8284-8290
URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8284.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8284